Ibuprofen Price Trend

Ibuprofen Price Trend, Index and Forecast

Track the latest insights on ibuprofen price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Ibuprofen Prices Outlook Q2 2025

• USA: US$ 10,992/MT 
• China: US$ 12,534/MT           
• Germany: US$ 10,790/MT     
• France: US$ 12,158/MT         
• Indonesia: US$ 11,422/MT

Ibuprofen Price Chart

Get real-time access to monthly/quaterly/yearly prices, Request Sample

During the second quarter of 2025, the ibuprofen prices in the USA reached 10,992 USD/MT in June. In the USA, ibuprofen prices in Q2 2025 were impacted by supply chain constraints related to the sourcing of key active pharmaceutical ingredients from overseas suppliers. Regulatory compliance costs and batch testing requirements contributed to production expenses. Demand fluctuations in the over-the-counter pharmaceutical sector, coupled with freight and warehousing cost variations, also influenced overall pricing dynamics during the quarter.

During the second quarter of 2025, ibuprofen prices in China reached 12,534 USD/MT in June. In China, ibuprofen pricing was influenced by raw material cost volatility, particularly for isobutylbenzene and acetic acid derivatives. Plant operating rates fluctuated due to environmental audits and emissions control policies. Export volumes to key global markets affected domestic supply balances. Additionally, energy prices and workforce availability across pharmaceutical manufacturing hubs played a role in shaping cost structures and price outcomes.

During the second quarter of 2025, the ibuprofen prices in Germany reached 10,790 USD/MT in June. In Germany, ibuprofen prices were affected by pharmaceutical manufacturing activity, which was influenced by environmental regulations and energy price trends. Import costs for intermediates and feedstocks contributed to shifts in production economics. Demand from both domestic healthcare providers and private-label pharmaceutical companies remained steady. Packaging material costs and distribution inefficiencies also played a part in determining final product pricing.

During the second quarter of 2025, the ibuprofen prices in France reached 12,158 USD/MT in June. In France, ibuprofen pricing was impacted by demand from the healthcare and consumer wellness sectors, alongside changes in the cost of pharmaceutical excipients and packaging components. Domestic production levels were shaped by labor availability and regulatory oversight. Import dependency for active ingredients influenced pricing sensitivity to currency movements and freight rate changes. Seasonal demand variations further affected inventory management and supply consistency.

During the second quarter of 2025, the ibuprofen prices in Indonesia reached 11,422 USD/MT in June. In Indonesia, ibuprofen prices in Q2 2025 were influenced by import reliance on raw materials and active pharmaceutical ingredients from India and China. Currency fluctuations against the US dollar affected landed costs. Demand from hospitals, pharmacies, and government procurement channels contributed to consumption levels. Logistics and port clearance delays, combined with domestic formulation capacity limitations, further shaped the pricing environment.

Ibuprofen Prices Outlook Q3 2024

• United States: US$ 10,700/MT
• China: US$ 22,100/MT
• Germany: US$ 10,470/MT

The ibuprofen prices in the United States for Q3 2024 reached 10,700 USD/MT in September. Prices experienced significant variability, marked by strong demand alongside limited inventories. Toward the closing of the quarter, prices rose marginally in comparison to Q2, with a notable spike during the second part of Q3. This pattern highlights the resilience and adaptability of the market concerning external challenges.

The price trend for ibuprofen in China for Q3 2024 settled at 22,100 USD/MT in September. The country exhibited notable price volatility due to stronger industrial productivity, high overseas requirements, and ongoing interruptions in supply networks. Q3 witnessed a notable rise in prices during the second half as compared to the first, maintaining market momentum regardless of a marginal decrease compared to Q2. This pattern highlights the durability of the ibuprofen industry amid continuous difficulties.

In Germany, the ibuprofen prices for Q3 2024 reached 10,470 USD/MT in September. The country experienced significant shifts in prices, following a persistent ascending trend and exhibiting notable improvement compared to Q2. Prices climbed continually throughout the quarter, highlighting an optimistic environment in Germany.

Ibuprofen Prices Outlook Q2 2024

• United States: US$ 22,800/MT
• China: US$ 10,650/MT
• Germany: US$ 10,450/MT

The ibuprofen prices in the United States for Q2 2024 reached 22,800 USD/MT in June. The country experienced significant price shifts driven by strong demand from end-use industries and proactive mass purchasing by distributors to mitigate challenges in the future. Seasonal elements, including the premature onset of the peak transportation period, further contributed to the price increase. This trend highlights the resilience of the market in the face of continual issues and reflects pragmatic responses by market participants, signaling a strong and steadily improving upward trajectory in prices.

The price trend for ibuprofen in China for Q2 2024 settled at 10,650 USD/MT in June. The country experienced significant fluctuations in prices due to heightened export activity and rising interest from both domestic and international clients.  Seasonal influences further contributed as industry players utilized this favorable environment toward the end of Q2. This rise in prices indicates an optimistic market sentiment driven by inventory limitations, economic influences, and the judicious adapting of prices by distributors.

In Germany, the ibuprofen prices for Q2 2024 reached 10,450 USD/MT in June. The country witnessed significant price volatility. The market exhibited a continuous upward trend due to strong requirements from end-use industries, severe inventory shortages, and pressures from inflation. Procurement activities notably increased in the second half of Q2, leading to a marked rise in prices in comparison to the former part. Toward the close of the quarter, ibuprofen prices reflected a positive trend, highlighting an optimistic industry outlook.

Ibuprofen Prices Outlook Q4 2023

• USA: US$ 9,510/MT
• China: US$ 21,515/MT
• Germany: US$ 9,870/MT

In the last quarter of 2023, there was an average decrease in ibuprofen prices in the United States. Stock prices dropped as a result of investors being wary due to growing inflation and possible recession fears. In addition, there was an excess of the commodity available due to an imbalance in supply and demand. In the end, Q4FY2023 saw ibuprofen prices in the USA hit 9,510 USD/MT.

Throughout the last quarter of 2023, the average cost of ibuprofen decreased in China. The nation's market was oversupplied with goods, which forced producers to reduce their profit margins in order to clear off their inventory. The price of ibuprofen in China ended the quarter at 21,515 USD/MT.

During Q4FY2023, Germany showed indications of an economic slowdown, which had an adverse effect on ibuprofen prices. Due to poor product demand, a delay in manufacturing, and large currency changes, prices fell in the first few months of Q4. By December, there was a discernible rise in ibuprofen prices as a result of more people purchasing the medication. At the end of the fourth quarter, prices were 9,870 USD/MT overall.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the ibuprofen prices.

Global Ibuprofen Price Trend

The report offers a holistic view of the global ibuprofen pricing trends in the form of ibuprofen price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of ibuprofen, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed ibuprofen demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Ibuprofen Price Trend

Q2 2025:

As per the ibuprofen price index, European ibuprofen prices in Q2 2025 were influenced by energy-intensive manufacturing costs, particularly due to electricity and gas price volatility. Regulatory compliance costs, especially related to emissions and pharmaceutical safety standards, impacted operating margins. Import dependency for key intermediates from Asia introduced price sensitivity to currency movements and freight fluctuations. Demand from the healthcare and private-label pharmaceutical sectors remained steady, shaping procurement strategies and inventory levels.

Q3 2024:

In the third quarter of 2024, ibuprofen prices in Europe witnessed a major price increase driven by several circumstances that impacted industry conditions. Rising manufacturing expenses in major production hubs, driven by higher feedstock and operational expenses, were a primary influence. This was further heightened by a notable rise in international requirements as various sectors boosted production to meet rising consumer needs. Supply network interruptions also influenced prices, with shortages caused by facility closures at vital manufacturing sites limiting supply and intensifying the pressure on prices. Additionally, currency fluctuations increased the costs of import, further influencing the upward pricing trend.

Q2 2024:

Throughout the second quarter of 2024, ibuprofen prices in Europe experienced a significant rise, driven mainly by increased manufacturing expenses and drastic interruptions in supply networks. Several factors contributed to this increase, including higher energy and raw material expenses and rising shipping costs, driven by international operational challenges. Environmental issues added to these supply network difficulties, creating bottlenecks. International challenges, such as the closure of major production facilities in Asia, added to the pressure on supply networks, prompting local participants to increase prices in order to control supply shortages and utilize trade openings. This trend of ongoing hikes in price and inventory constraints reflects a positive market environment.

Q4 2023:

The prices of ibuprofen in the European region declined during the final quarter of 2023. The initial two months of Q4 experienced a decline in demand and abundant product supply among key players, which prompted manufacturers to lower their quotations to destock inventories. However, in December, there was a noticeable increase in prices due to increased demand for ibuprofen among consumers.

This analysis can be extended to include detailed ibuprofen price information for a comprehensive list of countries.

North America Ibuprofen Price Trend

Q2 2025:

As per the ibuprofen price index, in North America, ibuprofen pricing was impacted by shifts in demand from the over-the-counter and institutional healthcare sectors. Supply chain disruptions for active pharmaceutical ingredients sourced from overseas affected production schedules. Regulatory inspection cycles and quality control requirements contributed to manufacturing costs. Additionally, distribution expenses, including warehousing and trucking rates, played a role in shaping the overall price structure during the quarter.

Q3 2024:

In Q3 2024, the North American ibuprofen market witnessed a marked increase in prices due to several contributing factors. A substantial rise in international demand, compounded by interruptions in supply networks, including logistical hurdles and plant closures, was a major contributor to the price escalation. Geopolitical pressures and increasing manufacturing expenses added further complexity to the pricing landscape, impacting ibuprofen availability. Overall, prices in the third quarter reflected an optimistic market sentiment, signaling strong industry performance and continued growth potential.

Q2 2024:

During the second quarter of 2024, ibuprofen prices in North America witnessed a notable increase owing to various circumstances. Ongoing interruptions in international supply networks, such as shipping delays, lack of containers, and global pressures, had a significant impact on the industry. Rising costs of energy and input material added to production expenses, contributing to the ascending pricing trend. Q2 also faced supply limitations due to maintenance activities and technical issues at major manufacturing facilities, tightening supply and driving prices higher.

Q4 2023:

In North America, the ibuprofen market underwent various challenges that affected the dynamics and price trends. Initially, the price declined because of global economic uncertainties, surplus availability of ibuprofen, and limited international demand. However, in December, the prices surge significantly because of increased freight charges, shortages of containers, and persistent congestion at the Panama Canal.

Specific ibuprofen historical data within the United States and Canada can also be provided.

Middle East and Africa Ibuprofen Price Trend

Q2 2025:

As per the ibuprofen price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences. A tight supply from refineries, exacerbated by maintenance rounds and unplanned outages, put pressure on prices. Simultaneously, demand from the agrochemical sector during the planting season contributed to price changes.

The report explores the ibuprofen pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on ibuprofen prices for countries can also be provided.

Asia Pacific Ibuprofen Price Trend

Q2 2025:

In the Asia Pacific region, ibuprofen prices were shaped by fluctuations in raw material availability, particularly for isobutylbenzene and acetic acid derivatives. Plant operations in major producing countries were affected by environmental compliance checks and labor-related constraints. Export demand from Western markets influenced regional supply allocation. Currency volatility and intra-regional trade logistics further contributed to cost variability across the pharmaceutical manufacturing hubs.

Q3 2024:

Throughout the third quarter of 2024, ibuprofen prices in Asia Pacific rose significantly due to numerous contributing factors. Supply challenges were primarily driven by interrupted operations, compounded by increased international requirements for exports from China. Seasonal closures of production facilities for maintenance added to supply constraints, tightening availability and driving prices higher. Furthermore, plant closures in various areas intensified these supply issues, emphasizing the sensitive supply-demand balance that shapes the pricing environment in Asia Pacific.

Q2 2024:

During the second quarter of 2024, ibuprofen prices in Asia Pacific witnessed a marked upward trend due to numerous contributing circumstances. Strong requirements from local and foreign markets drove prices higher, propelling distributors to revise strategies. Geopolitical pressures and operational challenges worsened inventory limitations, while fluctuations in currency raised manufacturing expenses. Additionally, planned facility closures for servicing and repairs further strained supplies, contributing to the upward pricing trajectory.

Q4 2023:

The Asia Pacific region experienced notable fluctuations in ibuprofen prices during the Q4 of 2023. The initial months of Q4 saw a decline in prices because of low to moderate demand and the availability of ample product supply. By December, the prices for ibuprofen rebounded due to an upswing in demand outlook.

This ibuprofen price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Ibuprofen Price Trend

Q2 2025:

Latin America's ibuprofen market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in ibuprofen prices. Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting the region's ability to meet international demand consistently. Moreover, the ibuprofen price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing ibuprofen pricing trends in this region.

The analysis of ibuprofen prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Ibuprofen Price Trend, Market Analysis, and News

IMARC's latest publication, “Ibuprofen Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the ibuprofen market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of ibuprofen at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed ibuprofen prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting ibuprofen pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Ibuprofen Market Analysis

The global ibuprofen market size reached USD 95.52 Million in 2024. By 2033​, IMARC Group expects the market to reach USD 120.34 Million, at a projected CAGR of 2.47% during 2025-2033.

• The heightened prevalence of chronic pain across the globe is bolstering the market share. Ibuprofen is a non-prescription pain relief solution that helps in alleviating arthritis, migraine headaches, and neuropathic pain. According to the World Health Organization (WHO), chronic diseases are on the rise globally, including those that cause severe pain. These diseases account for 41 million deaths, which is equivalent to 74% of all deaths worldwide. Also, according to the Centers for Disease Control and Prevention (CDC), the prevalence of chronic pain the US adults ranged from 20.5% to 21.8% between 2019 and 2021.
• The rising geriatric population has a profound impact on the expansion of the ibuprofen market. Geriatric individuals are affected by pain-causing conditions like osteoporosis, arthritis, and other musculoskeletal disorders. These conditions require effective pain management solutions like ibuprofen. According to recent findings, the proportion of the world’s population over 60 years will almost double from 12% to 22% between 2015 and 2050. Also, by 2050, 80% of the geriatric population will be present in low- and middle-income countries.
• Additionally, shifting consumer preferences towards self-medication and over-the-counter (OTC) drugs due to the desire for immediate relief, convenience, and perceived safety of OTC drugs. In this context, ibuprofen is considered a highly popular and trusted OTC pain reliever that provides relief from dental pain, headaches, minor injuries, and menstrual cramps. The latest findings show that 81% of adults prefer OTC medicines as a first response to minor ailments. In the US, a consumer makes around 26 trips/year to purchase OTC products. Also, there are more than 750000 retail outlets in the US that sell OTC products.
• The increasing healthcare spending around the world is an important factor in strengthening the market share. Countries are spending more on healthcare infrastructure to improve the availability and accessibility of medical treatment, including pain management solutions. For instance, in the European Union (EU), the general government spending on health amounted to €1221 billion or 7.7 % of GDP in 2022. Also, in the US, the healthcare spending grew by 4.1 percent, reaching $4.5 trillion or $13493/person.

Ibuprofen News

The report covers the latest developments, updates, and trends impacting the global ibuprofen industry, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in ibuprofen production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the ibuprofen price trend.

Latest developments in the ibuprofen industry:

• In August 2021, Alkem Laboratories announced the launch of ibuprofen and famotidine tablets in the US market.
• In November 2022, Salara Active Pharma bagged European certification for two manufacturing facilities for ibuprofen active pharmaceutical ingredients (API) in India.

Product Description

Ibuprofen (C₁₃H₁₈O₂), also known as Motrin, refers to a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid. It also functions as a radical scavenger, geroprotector, cyclooxygenase 2 inhibitor, and non-narcotic analgesic. Colorless and crystalline, ibuprofen dissolves well in water, alcohol, and other organic solvents. Its melting point is 75-77.5 ºC, its boiling point is 157ºC, and its molecular weight is 206.28 g/mol.

Isobutylbenzene and acetic anhydride are raw materials used in the synthesis of ibuprofen. These raw materials go through the Friedel-Crafts acylation, carbonyl reduction, chloride substitution, and Grignard reaction processes.

It is used to control and treat osteoarthritis, rheumatoid disorders, inflammatory diseases, mild pain, dysmenorrhea, fever, headache, tooth pain, cramping during menstruation, muscle pains, and colds. Ibuprofen is a reasonably priced, very effective medication that helps patients live better, heal more quickly, regulate body temperature, and lessen discomfort.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of ibuprofen pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting ibuprofen price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The ibuprofen price charts ensure our clients remain at the forefront of the industry.